Leadership Overview
Pacira has 4 executives leading key functions including finance, medical affairs, legal, and administration.
Driven by a commitment to improving patient outcomes, Pacira advances non-opioid pain management and regenerative health solutions, making a meaningful difference in communities worldwide.
Driven by a commitment to improving patient outcomes, Pacira advances non-opioid pain management and regenerative health solutions, making a meaningful difference in communities worldwide.
Leadership Roles at Pacira
Shawn Cross - Chief Financial Officer
Shawn Cross, the Chief Financial Officer at Pacira, directs all financial operations and strategic fiscal planning. Overseeing budgeting, forecasting, and capital allocation, the Chief Financial Officer ensures robust financial health and supports the company's growth initiatives in non-opioid pain management. Cross manages investor relations and financial reporting, maintaining transparency and compliance with Nasdaq regulations. This leadership role involves optimizing resource deployment to advance Pacira's mission of improving patient outcomes through innovative regenerative health solutions. By driving financial efficiency, Shawn Cross directly contributes to the company's ability to expand its market reach and develop new therapeutic offerings. Ultimately, Cross secures long-term financial stability and supports strategic investments in research and development.

Jonathan Slonin - Chief Medical Officer
Jonathan Slonin, the Chief Medical Officer at Pacira, guides the company's medical strategy and clinical development programs. Overseeing all medical affairs, the Chief Medical Officer ensures that Pacira's non-opioid pain management and regenerative health solutions meet the highest standards of patient care and efficacy. Slonin directs clinical research, medical education, and pharmacovigilance, aligning these functions with the company's core mission to improve patient outcomes. This critical role involves collaborating with healthcare professionals and regulatory bodies to advance the adoption of innovative treatments. By championing evidence-based medicine, Jonathan Slonin directly influences the development and deployment of Pacira's product pipeline. Ultimately, Slonin ensures that the company's scientific endeavors translate into tangible benefits for patients and healthcare providers.

Anthony Molloy - Chief Legal Officer & Chief Compliance Officer
Anthony Molloy, the Chief Legal Officer & Chief Compliance Officer at Pacira, oversees all legal affairs and ensures strict adherence to regulatory standards. Managing corporate governance, intellectual property, and litigation, the Chief Legal Officer & Chief Compliance Officer safeguards Pacira's operations and reputation. Molloy directs compliance programs, ensuring that all activities related to non-opioid pain management and regenerative health solutions align with ethical guidelines and legal frameworks. This executive function is vital for maintaining trust with stakeholders and navigating the complex regulatory landscape of the pharmaceutical industry. By providing expert legal counsel and robust compliance oversight, Anthony Molloy directly supports Pacira's commitment to advancing patient outcomes. Ultimately, Molloy ensures the company operates with integrity and within all applicable laws.

Kristen Williams - Chief Administrative Officer & Secretary
Kristen Williams, the Chief Administrative Officer & Secretary at Pacira, directs essential corporate functions and governance processes. Overseeing human resources, facilities management, and corporate communications, the Chief Administrative Officer & Secretary ensures efficient internal operations that support Pacira's mission. Williams manages board relations and corporate secretarial duties, facilitating effective communication and strategic alignment between leadership and the board of directors. This role is crucial for maintaining a productive work environment and ensuring seamless execution of administrative strategies that underpin the company's focus on non-opioid pain management and regenerative health solutions. By optimizing organizational structure and processes, Kristen Williams directly enhances Pacira's capacity to innovate and improve patient outcomes. Ultimately, Williams provides the operational framework necessary for sustained company growth and success.

Explore Leadership Teams in Manufacturing
Vertex Pharmaceuticals Incorporated is a biotechnology company that develops and commercializes medicines for serious diseases with significant unmet medical needs. Its portfolio includes therapies for cystic fibrosis, sickle cell disease, transfusion-dependent beta thalassemia, and acute pain. The company also advances research programs in kidney disease, type 1 diabetes, myotonic dystrophy, and other genetic disorders, serving patients through healthcare providers, specialty pharmacies, hospitals, and distributors worldwide.
Company Leadership
JL
DD
OG
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, and Trodelvy products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. The company has collaboration agreements with Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Arcellx, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company was incorporated in 1987 and is headquartered in Foster City, California.
Company Leadership ES
SS

BH
Amgen Inc. (Nasdaq: AMGN) is a leading American multinational biotechnology company headquartered in Thousand Oaks, California. Founded in 1980 as Applied Molecular Genetics, Amgen pioneered the biotech industry and remains at the forefront of scientific innovation.
Company Leadership LF

Organon creates, manufactures and markets innovative prescription medicines that improve the health and quality of human life. Through a combination of innovation and business partnerships, Organon seeks to leverage each of its core therapeutic fields.
Company Leadership
MM
JS
MA